Stay updated with breaking news from Markus barten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients vietreader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vietreader.com Daily Mail and Mail on Sunday newspapers.
Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the publication of findings from a retrospective, observational, single arm, European chart review study assessing the real-world use of extracorporeal photopheresis (ECP) and its impact on clinical outcomes in the modern era of heart transplantation.1 An online version of the data manuscript – the largest-known study of ECP in heart transplant patients – is currently published on the Journal of Hea ....
Results from the largest European and first multicenter, retrospective, observational chart review study investigating the real-world use of extracorporeal photopheresis (ECP) in heart transplant patients reinforce its use as a treatment for heart transplant rejection and prevention of rejection. ....
- Results from the largest European and first multicenter, retrospective, observational chart review study investigating the real-world use of ECP in heart transplant patients reinforce its ....
EQS-News: Biotest AG / Key word(s): StudyBiotest AG: First patient treated with Cytotect® CP Biotest in study after heart and lung transplantation 24.01.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement. PRESS RELEASE First patient treated with Cytotect® CP&n. ....